US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 49.860
  • +1.930+4.03%
Close Apr 26 16:00 ET
  • 49.860
  • 0.0000.00%
Post 16:01 ET
6.05BMarket Cap-11204P/E (TTM)

Apellis Pharmaceuticals Key Stats

Apellis Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 7, 2024

Revenue(YoY)

162.05M

+261.34%
EPS(YoY)

-0.47

+69.89%

Strong Buy

Apr 18, 2024

Apellis Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 188.922M--
May 7, 20242024/Q1-- / 162.047M--
Feb 27, 20242023/Q4146.377M / 143.592M--
Nov 1, 20232023/Q3110.399M / 99.054M--
Jul 31, 20232023/Q294.969M / 71.120M--
May 4, 20232023/Q144.846M / 26.105M--
--2022/Q422.663M / 24.518M--
Nov 7, 20222022/Q322.056M / 21.591M--
Aug 8, 20222022/Q216.322M / 16.945M--
May 4, 20222022/Q114.381M / 12.622M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 188.922M--
May 7, 20242024/Q1-- / 162.047M--
Feb 27, 20242023/Q4146.377M / 143.592M--
Nov 1, 20232023/Q3110.399M / 99.054M--
Jul 31, 20232023/Q294.969M / 71.120M--
May 4, 20232023/Q144.846M / 26.105M--
--2022/Q422.663M / 24.518M--
Nov 7, 20222022/Q322.056M / 21.591M--
Aug 8, 20222022/Q216.322M / 16.945M--
May 4, 20222022/Q114.381M / 12.622M--

Unlock Free Earnings Estimates

Apellis Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 18, 2024

Strong Buy

  • Buy

    76.92%
  • Hold

    23.08%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg